D-Wave Quantum (QBTS) Is Up 44.5% After $100 Million Planned Federal Equity Investment - What's Changed
D-Wave Quantum QBTS | 0.00 |
- D-Wave Quantum Inc. previously signed a Letter of Intent with the U.S. Department of Commerce under the CHIPS and Science Act to issue US$100,000,000 of common stock in exchange for federal support to accelerate its annealing and gate-model quantum systems and expand R&D facilities.
- This arrangement gives the U.S. government a minority equity stake in D-Wave, signaling federal confidence in its quantum technology while introducing potential dilution for existing shareholders.
- Next, we’ll examine how this planned US$100,000,000 federal equity investment could reshape D-Wave Quantum’s high-growth, loss-making investment narrative.
AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
D-Wave Quantum Investment Narrative Recap
To own D-Wave Quantum today, you really have to believe that quantum annealing and superconducting architectures will translate into a much broader, stickier QCaaS and systems business over time. The US$100,000,000 planned federal equity investment could strengthen near term funding visibility, but it does not remove the key short term risk that widening losses and heavy R&D spend continue without a matching ramp in recurring, multi year contracts.
In that context, the recent Q1 2026 earnings are hard to ignore: sales fell to US$2.86 million from US$15 million a year earlier while net loss widened to US$18.36 million. Set against the CHIPS Act letter of intent, that step down in revenue underlines how dependent D-Wave still is on lumpy system deals and why investors are watching upcoming contract signings so closely.
However, investors should be aware that if high ticket system sales remain sporadic and recurring QCaaS usage does not scale, then...
D-Wave Quantum's narrative projects $122.5 million in revenue and $15.2 million in earnings by 2028. This requires 71.8% yearly revenue growth and a $414.0 million earnings increase from -$398.8 million today.
Uncover how D-Wave Quantum's forecasts yield a $38.54 fair value, a 31% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were already assuming revenue could reach about US$180.2 million and earnings US$22.2 million by 2029, which is a far more bullish path than the baseline view and depends heavily on on prem system expansion; with the US$100,000,000 CHIPS Act stake now on the table, those expectations may shift again, so it is worth comparing how differently people see the same stock before you decide where you stand.
Explore 49 other fair value estimates on D-Wave Quantum - why the stock might be worth less than half the current price!
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your D-Wave Quantum research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
- Our free D-Wave Quantum research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate D-Wave Quantum's overall financial health at a glance.
Searching For A Fresh Perspective?
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
- Rare earth metals are the new gold rush. Find out which 27 stocks are leading the charge.
- Uncover the next big thing with 25 elite penny stocks that balance risk and reward.
- Capitalize on the AI infrastructure supercycle with our selection of the 46 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
